1
by Klemp, Marianne
Published 2007
Norwegian Knowledge Centre for the Health Services
... and histological endpoints within the tested time interval. No serious adverse events related to vaccination...

2
by Movik, Espen
Published 2012
Norwegian Knowledge Centre for the Health Services
... at the time of diagnosis. Palliative chemotherapy is the standard treatment for patients in NSCLC stages IIIB...

3
by Holte, Therese Opsahl, Goderstad, Jeanne Mette, Lieng, Marit, Busund, Bjørn
Published 2009
Norwegian Knowledge Centre for the Health Services
... infections and faster recovery compared with open surgery.3. The disadvantages are the longer operating time...

4
by Movik, Espen, Hamidi, Vida, Aaserud, Morten, Neilson, Aileen Rae
Published 2008
Norwegian Knowledge Centre for the Health Services
... The evidence base regarding the cost-effectiveness of cetuximab is, at the time of writing, weak, particularly...

5
by Jiménez, Enrique, Wisløff, Torbjørn, Klemp, Marianne
Published 2014
Norwegian Knowledge Centre for the Health Services
... approximately NOK 780/dose.3. From a societal perspective, i.e. when costs to patients for time used under...

6
by Ringerike, Tove, Hamidi, Vida, Hagen, Gunhild, Reikvam, Åsmund
Published 2011
Norwegian Knowledge Centre for the Health Services
... that calculated quality-adjusted life years and life time costs. The main findings were that:1. We did not find...

8
by Arentz-Hansen, Helene
Published 2014
Norwegian Knowledge Centre for the Health Services

9
by Heier, Hans Erik
Published 2005
Norwegian Knowledge Centre for the Health Services